Evaluation of a rapid test against two ELISAs for a SARS-CoV-2
seroprevalence survey in Kibera informal settlement, Nairobi, Kenya
Jane Y Carter1, Samoel Khamadi2,
Joseph Mwangi2, Samuel Muhula1,
Stephen M Munene1, Lucy Kanyara2,
Joyceline Kinyua2, Nancy Lagat2,
Judy Chege2, Robert Oira2, Alex
Maiyo2, Roy Stewart3, Maarten
Postma4,5, Jelle Stekelenburg4,6,
Marinus van Hulst4,7, Joachim Osur8
1 Amref Health Africa Headquarters, PO Box
27691–00506, Nairobi, Kenya
2Centre for Virus Research, Kenya Medical Research
Institute, PO Box 54840–00200, Nairobi, Kenya
3Department of Health Sciences, Community and
Occupational Medicine, University of Groningen, University Medical
Center Groningen, Groningen, the Netherlands
4Department of Health Sciences, Global Health,
University Medical Centre Groningen, University of Groningen, the
Netherlands
5Indonesian Affiliation Center of Excellence in Higher
Education for Pharmaceutical Care Innovation, Universitas Padjadjaran,
Bandung, Indonesia
6Department of Obstetrics and Gynaecology, Medical
Centre Leeuwarden, Leeuwarden, the Netherlands
7Department of Clinical Pharmacy and Toxicology,
Martini Hospital, Groningen, the Netherlands
8Amref International University, PO Box 27691–00506,
Nairobi, Kenya